The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Asthma Inhaler Device Market Research Report 2025

Global Asthma Inhaler Device Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1887695

No of Pages : 85

Synopsis

Asthma is a type of chronic lung disease that inflames and narrows the airways. The symptoms of the disease are inclusive of recurring periods of wheezing, shortness of breath, chest tightness, and coughing. Asthma inhalers are the medical devices which deliver medication to the patient’s body via the lungs.

The global Asthma Inhaler Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Asthma Inhaler Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Asthma Inhaler Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Asthma Inhaler Device include GlaxoSmithKline, Merck & Co, 3M, Aristopharma, SRS PHARMACEUTICALS and Intas Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Asthma Inhaler Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Inhaler Device.

Report Scope

The Asthma Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Inhaler Device market comprehensively. Regional market sizes, concerning products by Type, by Sale Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Asthma Inhaler Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sale Channel, and by regions.

By Company

  • GlaxoSmithKline
  • Merck & Co
  • 3M
  • Aristopharma
  • SRS PHARMACEUTICALS
  • Intas Pharmaceuticals

Segment by Type

  • Metered-Dose Inhaler
  • MDI with a Spacer
  • Dry-Powder Inhaler
  • Other

Segment by Sale Channel

  • Hospital
  • Clinics
  • Retail Pharmacies
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sale Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Inhaler Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Inhaler Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sale Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Asthma Inhaler Device Market Overview
1.1 Product Overview and Scope of Asthma Inhaler Device
1.2 Asthma Inhaler Device Segment by Type
1.2.1 Global Asthma Inhaler Device Market Value Comparison by Type (2024-2030)
1.2.2 Metered-Dose Inhaler
1.2.3 MDI with a Spacer
1.2.4 Dry-Powder Inhaler
1.2.5 Other
1.3 Asthma Inhaler Device Segment by Sale Channel
1.3.1 Global Asthma Inhaler Device Market Value by Sale Channel: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Global Asthma Inhaler Device Market Size Estimates and Forecasts
1.4.1 Global Asthma Inhaler Device Revenue 2019-2030
1.4.2 Global Asthma Inhaler Device Sales 2019-2030
1.4.3 Global Asthma Inhaler Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Inhaler Device Market Competition by Manufacturers
2.1 Global Asthma Inhaler Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Inhaler Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Inhaler Device Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Inhaler Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Inhaler Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Inhaler Device, Product Type & Application
2.7 Asthma Inhaler Device Market Competitive Situation and Trends
2.7.1 Asthma Inhaler Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Inhaler Device Players Market Share by Revenue
2.7.3 Global Asthma Inhaler Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Inhaler Device Retrospective Market Scenario by Region
3.1 Global Asthma Inhaler Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Inhaler Device Global Asthma Inhaler Device Sales by Region: 2019-2030
3.2.1 Global Asthma Inhaler Device Sales by Region: 2019-2024
3.2.2 Global Asthma Inhaler Device Sales by Region: 2025-2030
3.3 Global Asthma Inhaler Device Global Asthma Inhaler Device Revenue by Region: 2019-2030
3.3.1 Global Asthma Inhaler Device Revenue by Region: 2019-2024
3.3.2 Global Asthma Inhaler Device Revenue by Region: 2025-2030
3.4 North America Asthma Inhaler Device Market Facts & Figures by Country
3.4.1 North America Asthma Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Inhaler Device Sales by Country (2019-2030)
3.4.3 North America Asthma Inhaler Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Inhaler Device Market Facts & Figures by Country
3.5.1 Europe Asthma Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Inhaler Device Sales by Country (2019-2030)
3.5.3 Europe Asthma Inhaler Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Inhaler Device Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Inhaler Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Inhaler Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Inhaler Device Market Facts & Figures by Country
3.7.1 Latin America Asthma Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Inhaler Device Sales by Country (2019-2030)
3.7.3 Latin America Asthma Inhaler Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Inhaler Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Inhaler Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Inhaler Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Inhaler Device Sales by Type (2019-2030)
4.1.1 Global Asthma Inhaler Device Sales by Type (2019-2024)
4.1.2 Global Asthma Inhaler Device Sales by Type (2025-2030)
4.1.3 Global Asthma Inhaler Device Sales Market Share by Type (2019-2030)
4.2 Global Asthma Inhaler Device Revenue by Type (2019-2030)
4.2.1 Global Asthma Inhaler Device Revenue by Type (2019-2024)
4.2.2 Global Asthma Inhaler Device Revenue by Type (2025-2030)
4.2.3 Global Asthma Inhaler Device Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Inhaler Device Price by Type (2019-2030)
5 Segment by Sale Channel
5.1 Global Asthma Inhaler Device Sales by Sale Channel (2019-2030)
5.1.1 Global Asthma Inhaler Device Sales by Sale Channel (2019-2024)
5.1.2 Global Asthma Inhaler Device Sales by Sale Channel (2025-2030)
5.1.3 Global Asthma Inhaler Device Sales Market Share by Sale Channel (2019-2030)
5.2 Global Asthma Inhaler Device Revenue by Sale Channel (2019-2030)
5.2.1 Global Asthma Inhaler Device Revenue by Sale Channel (2019-2024)
5.2.2 Global Asthma Inhaler Device Revenue by Sale Channel (2025-2030)
5.2.3 Global Asthma Inhaler Device Revenue Market Share by Sale Channel (2019-2030)
5.3 Global Asthma Inhaler Device Price by Sale Channel (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Asthma Inhaler Device Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Corporation Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck & Co Asthma Inhaler Device Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 3M
6.3.1 3M Corporation Information
6.3.2 3M Description and Business Overview
6.3.3 3M Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 3M Asthma Inhaler Device Product Portfolio
6.3.5 3M Recent Developments/Updates
6.4 Aristopharma
6.4.1 Aristopharma Corporation Information
6.4.2 Aristopharma Description and Business Overview
6.4.3 Aristopharma Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aristopharma Asthma Inhaler Device Product Portfolio
6.4.5 Aristopharma Recent Developments/Updates
6.5 SRS PHARMACEUTICALS
6.5.1 SRS PHARMACEUTICALS Corporation Information
6.5.2 SRS PHARMACEUTICALS Description and Business Overview
6.5.3 SRS PHARMACEUTICALS Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 SRS PHARMACEUTICALS Asthma Inhaler Device Product Portfolio
6.5.5 SRS PHARMACEUTICALS Recent Developments/Updates
6.6 Intas Pharmaceuticals
6.6.1 Intas Pharmaceuticals Corporation Information
6.6.2 Intas Pharmaceuticals Description and Business Overview
6.6.3 Intas Pharmaceuticals Asthma Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intas Pharmaceuticals Asthma Inhaler Device Product Portfolio
6.6.5 Intas Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Inhaler Device Industry Chain Analysis
7.2 Asthma Inhaler Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Inhaler Device Production Mode & Process
7.4 Asthma Inhaler Device Sales and Marketing
7.4.1 Asthma Inhaler Device Sales Channels
7.4.2 Asthma Inhaler Device Distributors
7.5 Asthma Inhaler Device Customers
8 Asthma Inhaler Device Market Dynamics
8.1 Asthma Inhaler Device Industry Trends
8.2 Asthma Inhaler Device Market Drivers
8.3 Asthma Inhaler Device Market Challenges
8.4 Asthma Inhaler Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’